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Primary Cutaneous Carcinosarcoma
A cutaneous neoplasm with an exceptional presentation
*Ricardo Ruiz-Villaverde1 and José Aneiros-Fernández2
An 85-year-old woman with a history of hypertension and diabetes mellitus was referred to the Dermatology Outpatient Clinic 
of the Complejo Hospitalario de Granada, Granada, 
Spain, in 2016 with an excrescent tumour on her 
upper forehead measuring 8 mm in diameter that had 
been present for the past two years [Figure 1]. She had 
been exposed to significant ultraviolet (UV) radiation 
and undergone excision of two basal cell carcinomas 
(BCCs) 10 years prior. Upon physical examination, the 
lymph nodes were not palpable and there was no evid-
ence of hepatosplenomegaly.
A blood cell count and general biochemistry tests 
showed no abnormalities. The tumour was removed via 
complete conventional surgical excision with a 1 cm 
margin. Upon histological examination, the neoplasia 
consisted of  double cellular components. The first comp-
rised typical BCC cells, while the other was composed 
of short spindle cells with moderate pleomorphism 
and pronounced mitotic activity corresponding to 
epithelial and sarcomatous components, respectively 
[Figure 2]. An immunohistochemical analysis revealed 
the BCC component to be cytokeratin (CK) AE1/AE3-
positive and vimentin-negative, while the sarcomatous 
component was CK-negative and vimentin-positive 
[Figure 3]. At a follow-up appointment one year later, 
there was no evidence of recurrence of the lesion.
Comment
Visceral carcinosarcomas have been described in num- 
erous locations, including the adrenal glands, breast 
tissue, colon, endometrium, lungs and urogenital tract.1 
First described in 1953, cutaneous carcinosarcomas 
(CCSs) are uncommon cutaneous neoplasms involving 
biphasic malignant epithelial and sarcomatous comp-
onents.2 The epithelial component is represented by a 
BCC, squamous cell carcinoma or adnexal carcinoma 
of the skin such as a porocarcinoma, trichilemmal 
cystic carcinoma or spiradenocarcinoma, whereas the 
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Figure 1: Photograph of an excrescent ulcerated tumour on the upper forehead of an 85-year-old woman.
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In CCS cases, Mohs micrographic surgery is the 
treatment of choice and has been reported to result in 
a cure rate of ≥98%; in contrast, a recurrence rate of 
33% has been reported without this surgery.4 As such, 
close observation of the patient is required if Mohs 
surgery is not performed. There is no evidence to 
support the use of adjuvant radiotherapy. The prev-
alence of metastasis in CCS with a basal cell epith- 
elial component has been reported in 2% of cases.4,5
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sarcomatous component is formed of an osteosarcoma, 
chondrosarcoma, fibrosarcoma or malignant fibrous 
histiocytoma.3 
The diagnostic criteria for a CCS include an 
absence of transitional areas in the malignant comp-
onents and lack of cytokeratin expression in the sar-
comatous components.3 However, Müller’s criteria 
should be additionally considered to more thoroughly 
confirm the diagnosis.4 According to Müller et al., a 
CCS is a malignant entity composed of two well- 
defined cell populations as evidenced by conventional 
histology (i.e. haematoxylin and eosin stains) and an 
adequate immunohistochemical panel. Metastases from 
distant sites and sarcomatous changes in the stroma 
of the neoplasm should also be excluded.4
There are at least four aetiopathogenic theories 
to explain the genesis of CCS. Of these, the monoc- 
lonal theory is particularly important as it justifies 
the rapid growth of the lesion by implicating the 
metaplastic transformation of the sarcomatous com- 
ponent.5 Other theories to explain the pathogenesis 
of this variety of tumour are polyclonal-, collision- 
and composition-based.4 From a clinical perspective, 
CCSs typically occur in damaged and sun-exposed skin. 
In the current case, the presence of p53 mutations in 
the two components of the neoplasm confirms the role 
of UV radiation as a triggering factor.5
 
Figure 2: Haematoxylin and eosin stains at (A) x2 magnification showing the panoramic pathological view of the lesion 
and (B) x10 magnification showing a biphasic tumour with an epithelial component (atypical basaloid proliferation) and 
a sarcomatous component (pleomorphic spindle cells). No vascular or perineural invasion was detected.
 
Figure 3: Immunohistochemistry stains at x20 magnification showing (A) cytokeratin AE1/AE3-positivity in the epith-
elial component and (B) vimentin-positivity in the sarcomatous component of the lesion.
